CircAKR1B10 interacts with EIF4A3 to stabilize AURKA and promotes IL-22-induced proliferation, migration and invasion in keratinocytes
- PMID: 39177716
- DOI: 10.1007/s00403-024-03302-8
CircAKR1B10 interacts with EIF4A3 to stabilize AURKA and promotes IL-22-induced proliferation, migration and invasion in keratinocytes
Abstract
Circular RNAs (circRNAs) are demonstrated to be involved in psoriasis progression. CircRNAs can act as RNA-binding protein (RBP) sponges. Here, we investigated the action of circAKR1B10 in psoriasis, and explored the potential proteins interacted with circAKR1B10. Levels of genes and proteins were assayed by qRT-PCR and western blotting analyses. Keratinocytes in functional groups were treated with interleukin (IL)-22. Functional analysis were conducted using MTT, 5-ethynyl-2'-deoxyuridine (EdU), and transwell assays, respectively. Interaction analysis among circAKR1B10, Eukaryotic initiation factor 4 A-III (EIF4A3) and Aurora Kinase A (AURKA) was conducted using bioinformatics analysis, RNA pull-down assay, and RNA immunoprecipitation (RIP) assay. CircAKR1B10 was highly expressed in psoriasis patients and IL-22-induced keratinocytes. Functionally, knockdown of circAKR1B10 abolished IL-22-induced proliferation, migration and invasion in keratinocytes. AURKA expression was also higher in psoriasis patients and IL-22-induced keratinocytes, and was negatively correlated with circAKR1B10 expression. Moreover, AURKA silencing reduced the proliferative, migratory and invasive abilities of IL-22-induced keratinocytes. Mechanistically, circAKR1B10 interacted with EIF4A3 protein to stabilize and regulate AURKA expression. CircAKR1B10 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes via up-regulating AURKA expression through interacting with EIF4A3 protein.
Keywords: AURKA; EIF4A3; IL-22; Keratinocytes; Psoriasis; circAKR1B10.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
WTAP mediated m6A-modified circ_0056856 contributes to the proliferation, migration, and invasion of IL-22-stimulated human keratinocyte by miR-197-3p/CDK1 axis.Arch Dermatol Res. 2024 May 24;316(6):208. doi: 10.1007/s00403-024-03097-8. Arch Dermatol Res. 2024. PMID: 38787443
-
EIF4A3-induced circ_0084615 contributes to the progression of colorectal cancer via miR-599/ONECUT2 pathway.J Exp Clin Cancer Res. 2021 Jul 12;40(1):227. doi: 10.1186/s13046-021-02029-y. J Exp Clin Cancer Res. 2021. PMID: 34253241 Free PMC article.
-
EIF4A3-induced circular RNA MMP9 (circMMP9) acts as a sponge of miR-124 and promotes glioblastoma multiforme cell tumorigenesis.Mol Cancer. 2018 Nov 23;17(1):166. doi: 10.1186/s12943-018-0911-0. Mol Cancer. 2018. PMID: 30470262 Free PMC article.
-
Circ_0061012 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes through miR-194-5p/GAB1 axis in psoriasis.Biosci Rep. 2021 Jan 29;41(1):BSR20203130. doi: 10.1042/BSR20203130. Biosci Rep. 2021. PMID: 33393621 Free PMC article.
-
Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.BMC Cancer. 2024 Feb 21;24(1):239. doi: 10.1186/s12885-024-11984-6. BMC Cancer. 2024. PMID: 38383334 Free PMC article.
Cited by
-
Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib.Pharmaceuticals (Basel). 2025 Jun 20;18(7):936. doi: 10.3390/ph18070936. Pharmaceuticals (Basel). 2025. PMID: 40732226 Free PMC article.
References
-
- Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J, Psoriasis (2021) Lancet 397(10281):1301–1315. https://doi.org/10.1016/s0140-6736(20)32549-6 - DOI - PubMed
-
- Wei L, Chen S, Zhang Z et al (2022) Prevalence of Tobacco Smoking and its Association with Disease Severity among patients with psoriasis in China: a cross-sectional study. Front Med (Lausanne) 9(883458). https://doi.org/10.3389/fmed.2022.883458
-
- Kaplon H, Chenoweth A, Crescioli S, Reichert JM (2022) Antibodies to watch in 2022. MAbs 14(1):2014296. https://doi.org/10.1080/19420862.2021.2014296 - DOI - PubMed - PMC
-
- Dave R, Alkeswani A (2021) An overview of Biologics for Psoriasis. J Drugs Dermatol 20(11):1246–1247. https://doi.org/10.36849/jdd.6040 - DOI - PubMed
-
- Zhou X, Chen Y, Cui L, Shi Y, Guo C (2022) Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death Dis 13(1):81. https://doi.org/10.1038/s41419-022-04523-3 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous